AngioDynamics | ANGO - Cost Of Sales

Stock Price
10.44
Daily Change
-0.03 -0.29%
Monthly
-2.16%
Yearly
10.36%
Q2 Forecast
9.53

AngioDynamics reported $37.29M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 35.16M 2.23M Dec/2025
Boston Scientific USD 1.84B 82M Dec/2025
Edwards Lifesciences USD 343M 2.2M Dec/2025
ICU Medical USD 337.72M 1.61M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
J&J USD 8.07B 103M Mar/2026
Medtronic USD 3.61B 83M Dec/2025
Merit Medical Systems USD 198.58M 838K Dec/2025
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 66.63M 6.4M Dec/2025
Smiths GBP 544M 494M Jun/2026
Surmodics USD 9.49M 23.54M Jun/2025
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 261.54M 199.84M Dec/2025
Terumo JPY 143.44B 15.47B Dec/2025
Trinity Biotech USD 7.84M 3.14M Sep/2025